ClinConnect ClinConnect Logo
Search / Trial NCT05813236

NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery

Launched by AESCULAP AG · Apr 3, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Resective Periodontal Surgery

ClinConnect Summary

This clinical trial is comparing two types of suture materials—Novosyn Quick and Monosyn Quick—to see if they work equally well for healing after a specific type of gum surgery called resective periodontal surgery. The goal is to determine if both sutures lead to similar results in terms of wound healing, which will be measured by looking at signs like how well the skin is healing, bleeding control, and inflammation about 10 days after surgery.

To be eligible for this trial, participants need to be adults who are scheduled for this type of surgery and have given their consent for data collection. However, those with certain conditions, such as being pregnant or taking medications that could affect healing, won't be able to join. If you participate, you can expect to be monitored for any complications, how easy the sutures are to use, your pain levels, and how satisfied you are with the treatment. Overall, this study aims to ensure that both types of sutures are safe and effective for patients undergoing gum surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Adult patient undergoing resective periodontal surgery abd one of the incisions below has been performed:
  • Crestal incision
  • Vertical incision
  • Intrasulcular incision
  • Submarginal incision
  • Written informed consent regarding the data collection for the RCT
  • Exclusion Criteria:
  • Emergency surgery.
  • Pregnancy.
  • Breastfeeding
  • Patients taking medication that might affect wound healing.
  • Patients having a condition that might affect wound healing.
  • Patients with hypersensitivity or allergy to the suture material

About Aesculap Ag

Aesculap AG is a prominent global medical device manufacturer specializing in surgical instruments, implants, and innovative healthcare solutions. With a rich history rooted in excellence and innovation, Aesculap AG is dedicated to advancing surgical practices through cutting-edge technology and a commitment to improving patient outcomes. The company collaborates with healthcare professionals and institutions to conduct clinical trials that evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of quality and performance. Through its rigorous research and development initiatives, Aesculap AG aims to contribute significantly to the field of medicine and enhance the standards of surgical care worldwide.

Locations

Sant Cugat Del Vallès, Catalunya, Spain

Patients applied

0 patients applied

Trial Officials

Carolina Mor Reinoso, Dra.

Principal Investigator

Facultat d'Odontologia. Universitat Internacional de Catalunya

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials